Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (181-190 of 384) with videos related to

Pageof 39
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancerThomas John, Naoki Yanagawa, Derek Kohler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancerMing-Sound Tsao, Akira Sakurada, Keyue Ding, et al.
JNCI Cancer Spectrum|July 31, 2019
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort StudyDavendra P S Sohal, Nicole M Kuderer, Frances A Shepherd, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2020
Retrospective study of the incidence and outcomes from lung cancer in solid organ transplant recipientsKelvin Young, Haiyan Jiang, Max Marquez, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2013
Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancerJean-Louis Pujol, Robert Pirker, Thomas J Lynch, et al.
The Journal of Pain|May 1, 2014
Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer painLynn R Gauthier, Alycia Young, Robert H Dworkin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trialRodryg Ramlau, Vera Gorbunova, Tudor Eliade Ciuleanu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Pageof 39

Showing results (181-190 of 384) with videos related to

Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancerThomas John, Naoki Yanagawa, Derek Kohler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancerMing-Sound Tsao, Akira Sakurada, Keyue Ding, et al.
JNCI Cancer Spectrum|July 31, 2019
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort StudyDavendra P S Sohal, Nicole M Kuderer, Frances A Shepherd, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2020
Retrospective study of the incidence and outcomes from lung cancer in solid organ transplant recipientsKelvin Young, Haiyan Jiang, Max Marquez, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2013
Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancerJean-Louis Pujol, Robert Pirker, Thomas J Lynch, et al.
The Journal of Pain|May 1, 2014
Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer painLynn R Gauthier, Alycia Young, Robert H Dworkin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trialRodryg Ramlau, Vera Gorbunova, Tudor Eliade Ciuleanu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Pageof 39